Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Active Malaria Epidemiology Cohort Study With Evaluation of a 2 Day Versus 3 Day Treatment Regimen of Dihydroartemisinin (DHA)-Piperaquine for Patients With Uncomplicated Malaria

NCT01280162 is registered in ClinicalTrials.gov with Armed Forces Research Institute of Medical Sciences, Thailand as lead sponsor.

NCT NCT01280162
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01280162 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Active Malaria Epidemiology Cohort Study With Evaluation of a 2 Day Versus 3 Day Treatment Regimen of Dihydroartemisinin (DHA)-Piperaquine for Patients With Uncomplicated Malaria
Lead sponsor
Armed Forces Research Institute of Medical Sciences, Thailand
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2010
Completion date
December 31, 2012
Enrollment
222 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria